Inferior Vena Cava Filters—Current Role and Controversies

Abstract

Inferior vena cava filters (IVCFs) remain an indispensable part of an interventionalist's toolbox. Increased recognition of filter-related complications, largely from off-label use and casual approach to filter retrieval, has led to tremendous uncertainty surrounding their use. More stringent regulations on their use and development of newer and safer anticoagulants are gradually changing their role in the management of venous thromboembolism. Herein, the authors review the current role of IVCFs, indications for their use and retrieval, as well as filter-related complications.

Keywords

inferior vena cava filter - venous thromboembolism - retrievable filter - anticoagulation - temporary filter - optional filter - superior vena cava filter

• References

• 1 Duffett L, Carrier M. Inferior vena cava filters. J Thromb Haemost 2017; 15 (01) 3-12
• 2 White RH, Geraghty EM, Brunson A. et al. High variation between hospitals in vena cava filter use for venous thromboembolism. JAMA Intern Med 2013; 173 (07) 506-512
• 3 Glocker RJ, TerBush MJ, Hill EL. et al. Bundling of reimbursement for inferior vena cava filter placement resulted in significantly decreased utilization between 2012 and 2014. Ann Vasc Surg 2017; 38: 172-176
• 4 Ahmed O, Jilani S, Heussner D, Khan M. Trapped by controversy: inferior vena cava filters and the law. J Vasc Interv Radiol 2017; 28 (06) 886-888
• 5 Wadhwa V, Trivedi PS, Chatterjee K. et al. Decreasing utilization of inferior vena cava filters in post-FDA warning era: insights from 2005 to 2014 Nationwide Inpatient Sample. J Am Coll Radiol 2017; 14 (09) 1144-1150
• 6 Ryu RK, Parikh P, Gupta R. et al. Optimizing IVC filter utilization: a prospective study of the impact of interventional radiologist consultation. J Am Coll Radiol 2012; 9 (09) 657-660
• 7 Bartholomew JR. Update on the management of venous thromboembolism. Cleve Clin J Med 2017; 84 (12) (Suppl. 03) 39-46
• 8 Goldhaber SZ, Bounameaux H. Pulmonary embolism and deep vein thrombosis. Lancet 2012; 379 9828 1835-1846
• 9 Rodger M, Carrier M, Gandara E, Le Gal G. Unprovoked venous thromboembolis: short term or indefinite anticoagulation?. Balancing long-term risk and benefit. Blood Rev 2010; 24 (04) [phone]
• 10 Kearon C, Akl EA, Ornelas J. et al. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest 2016; 149 (02) 315-352
• 11 Kaufman JA, Kinney TB, Streiff MB. et al. Guidelines for the use of retrievable and convertible vena cava filters: report from the society of interventional radiology multidisciplinary consensus conference. World J Surg 2007; 31: 251-264
• 12 Brown JD, Talbert JC. Hospital variation and patient characteristics associated with vena cava filter use for venous thromboembolism. Pharmacoepidemiol Drug Saf 2016; 25: 64-65
• 13 Lee MJ, Valenti D, de Gregorio MA, Minocha J, Rimon U, Pellerin O. The CIRSE retrievable IVC filter registry: retrieval success rates in practice. Cardiovasc Intervent Radiol 2015; 38 (06) 1502-1507
• 14 Oh K, Hingorani A. Outcomes and associated factors in malpractice litigation involving inferior vena cava filters. J Vasc Surg Venous Lymphat Disord 2018; 6 (04) 541-544
• 15 Kaufman JA. Inferior vena cava filters: current and future concepts. Interv Cardiol Clin 2018; 7 (01) 129-135
• 16 PREPIC Study Group. Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC (Prevention du Risque d'Embolie Pulmonaire par Interruption Cave) randomized study. Circulation 2005; 112 (03) 416-422
• 17 Mismetti P, Laporte S, Pellerin O. et al; PREPIC2 Study Group. Effect of a retrievable inferior vena cava filter plus anticoagulation vs anticoagulation alone on risk of recurrent pulmonary embolism: a randomized clinical trial. JAMA 2015; 313 (16) 1627-1635
• 18 Stein PD, Matta F. Vena cava filters in unstable elderly patients with acute pulmonary embolism. Am J Med 2014; 127 (03) 222-225
• 19 White RH, Brunson A, Romano PS, Li Z, Wun T. Outcomes after vena cava filter use in noncancer patients with acute venous thromboembolism. Circulation 2016; 133 (21) 2018-2029
• 20 Wadhwa V, Gutta NB, Trivedi PS. et al. In-hospital mortality benefit of inferior vena cava filters in patients with pulmonary embolism and congestive heart failure. AJR Am J Roentgenol 2018; 211 (03) 672-676
• 21 Caplin DM, Nikolic B, Kalva SP, Ganguli S, Saad WE, Zuckerman DA. Society of Interventional Radiology Standards of Practice Committee. Quality improvement guidelines for the performance of inferior vena cava filter placement for the prevention of pulmonary embolism. J Vasc Interv Radiol 2011; 22 (11) 1499-1506
• 22 Jia Z, Wu A, Tam M, Spain J, McKinney JM, Wang W. Caval penetration by inferior vena cava filters: a systematic literature review of clinical significance and management. Circulation 2015; 132 (10) 944-952
• 23 Angel LF, Tapson V, Galgon RE, Restrepo MI, Kaufman J. Systematic review of the use of retrievable inferior vena cava filters. J Vasc Interv Radiol 2011; 22 (11) 1522-1530.e3
• 24 Morales JP, Li X, Irony TZ, Ibrahim NG, Moynahan M, Cavanaugh KJ. Decision analysis of retrievable inferior vena cava filters in patients without pulmonary embolism. J Vasc Surg Venous Lymphat Disord 2013; 1 (04) 376-384
• 25 Andreoli JM, Lewandowski RJ, Vogelzang RL, Ryu RK. Comparison of complication rates associated with permanent and retrievable inferior vena cava filters: a review of the MAUDE database. J Vasc Interv Radiol 2014; 25 (08) 1181-1185
• 26 Deso SE, Idakoji IA, Kuo WT. Evidence-based evaluation of inferior vena cava filter complications based on filter type. Semin Intervent Radiol 2016; 33 (02) 93-100
• 27 Eifler AC, Lewandowski RJ, Gupta R. et al. Optional or permanent: clinical factors that optimize inferior vena cava filter utilization. J Vasc Interv Radiol 2013; 24 (01) 35-40
• 28 Guez D, Hansberry DR, Eschelman DJ. et al. Inferior vena cava filter placement and retrieval rates among radiologists and nonradiologists. J Vasc Interv Radiol 2018; 29 (04) 482-485
• 29 Medical MS-DRG 301: Peripheral vascular disorders (weight 0.6679) estimated reimbursement $8,059 versus Surgical MS DRG-254: Other vascular procedures (weight 1.6609) estimated reimbursement $20,040. n.d. Available at: https://www.cms.gov/Research-Statistics-Data-and-Systems/Research-Statistics-Data-and-Systems.html Accessed October 11, 2018
• 30 Prasad V, Rho J, Cifu A. The inferior vena cava filter: how could a medical device be so well accepted without any evidence of efficacy?. JAMA Intern Med 2013; 173 (07) 493-495 discussion 495
• 31 Desai KR, Lewandowski RJ, Salem R. et al. Retrieval of inferior vena cava filters with prolonged dwell time: a single-center experience in 648 retrieval procedures. JAMA Intern Med 2015; 175 (09) 1572-1574
• 32 Kumar BCA, Chakraverty S, Zealley I. Removal of a permanent IVC filter. Cardiovasc Intervent Radiol 2006; 29 (01) 124-125
• 33 Kearon C, Akl EA, Ornelas J. et al. Antithrombotic therapy for VTE. Chest 2016; 149 (02) 315-352
• 34 Schulman S, Zondag M, Linkins L. et al. Recurrent venous thromboembolism in anticoagulated patients with cancer: management and short-term prognosis. J Thromb Haemost 2015; 13 (06) 1010-1018
• 35 Carrier M, Le Gal G, Cho R, Tierney S, Rodger M, Lee AY. Dose escalation of low molecular weight heparin to manage recurrent venous thromboembolic events despite systemic anticoagulation in cancer patients. J Thromb Haemost 2009; 7 (05) 760-765
• 36 Ahmad I, Yeddula K, Wicky S, Kalva SP. Clinical sequelae of thrombus in an inferior vena cava filter. Cardiovasc Intervent Radiol 2010; 33 (02) 285-289
• 37 Habito CR, Kalva SP. Inferior vena cava filter thrombosis: a review of current concepts, evidence, and approach to management. Hosp Pract (1995) 2011; 39 (03) 79-86
• 38 Vedantham S, Vesely TM, Parti N. et al. Endovascular recanalization of the thrombosed filter-bearing inferior vena cava. J Vasc Interv Radiol 2003; 14 (07) 893-903
• 39 Alkhouli M, Morad M, Narins CR, Raza F, Bashir R. Inferior Vena Cava Thrombosis. JACC Cardiovasc Interv 2016; 9 (07) 629-643
• 40 Kuo WT, Odegaard JI, Rosenberg JK, Hofmann LV. Laser-assisted removal of embedded vena cava filters: a 5-year first-in-human study. Chest 2017; 151 (02) 417-424
• 41 Muñoz FJ, Mismetti P, Poggio R. et al; RIETE Investigators. Clinical outcome of patients with upper-extremity deep vein thrombosis: results from the RIETE Registry. Chest 2008; 133 (01) 143-148
• 42 Joffe HV, Kucher N, Tapson VF, Goldhaber SZ. Deep Vein Thrombosis (DVT) FREE Steering Committee. Upper-extremity deep vein thrombosis: a prospective registry of 592 patients. Circulation 2004; 110 (12) 1605-1611
• 43 Bleker SM, van Es N, Kleinjan A. et al. Current management strategies and long-term clinical outcomes of upper extremity venous thrombosis. J Thromb Haemost 2016; 14 (05) 973-981
• 44 Kooij JD, van der Zant FM, van Beek EJ, Reekers JA. Pulmonary embolism in deep venous thrombosis of the upper extremity: more often in catheter-related thrombosis. Neth J Med 1997; 50 (06) 238-242
• 45 Ascher E, Hingorani A, Tsemekhin B, Yorkovich W, Gunduz Y. Lessons learned from a 6-year clinical experience with superior vena cava Greenfield filters. J Vasc Surg 2000; 32 (05) 881-887
• 46 Owens CA, Bui JT, Knuttinen MG, Gaba RC, Carrillo TC. Pulmonary embolism from upper extremity deep vein thrombosis and the role of superior vena cava filters: a review of the literature. J Vasc Interv Radiol 2010; 21 (06) 779-787
• 47 Carlon TA, Sudheendra D. Interventional therapy for upper extremity deep vein thrombosis. Semin Intervent Radiol 2017; 34 (01) 54-60
• 48 Singer AJ, Wilson S. Reversal strategies for newer oral anticoagulants. AACN Adv Crit Care 2017; 28 (04) 322-331
• 49 Rogers FB, Strindberg G, Shackford SR. et al. Five-year follow-up of prophylactic vena cava filters in high-risk trauma patients. Arch Surg 1998; 133 (04) 406-411 discussion 412
• 50 Haut ER, Garcia LJ, Shihab HM. et al. The effectiveness of prophylactic inferior vena cava filters in trauma patients: a systematic review and meta-analysis. JAMA Surg 2014; 149 (02) 194-202
• 51 Kidane B, Madani AM, Vogt K, Girotti M, Malthaner RA, Parry NG. The use of prophylactic inferior vena cava filters in trauma patients: a systematic review. Injury 2012; 43 (05) 542-547
• 52 Hemmila MR, Osborne NH, Henke PK. et al. Prophylactic inferior vena cava filter placement does not result in a survival benefit for trauma patients. Ann Surg 2015; 262 (04) 577-585
• 53 Cook AD, Gross BW, Osler TM. et al. Vena cava filter use in trauma and rates of pulmonary embolism, 2003–2015. JAMA Surg 2017; 152 (08) 724-732
• 54 Gargiulo III NJ, Veith FJ, Lipsitz EC, Suggs WD, Ohki T, Goodman E. Experience with inferior vena cava filter placement in patients undergoing open gastric bypass procedures. J Vasc Surg 2006; 44 (06) 1301-1305
• 55 Vaziri K, Bhanot P, Hungness ES, Morasch MD, Prystowsky JB, Nagle AP. Retrievable inferior vena cava filters in high-risk patients undergoing bariatric surgery. Surg Endosc 2009; 23 (10) 2203-2207
• 56 Rowland SP, Dharmarajah B, Moore HM. et al. Inferior vena cava filters for prevention of venous thromboembolism in obese patients undergoing bariatric surgery: a systematic review. Ann Surg 2015; 261 (01) 35-45
• 57 Harris SA, Velineni R, Davies AH. Inferior vena cava filters in pregnancy: a systematic review. J Vasc Interv Radiol 2016; 27 (03) 354-60.e8
• 58 Noble SI, Shelley MD, Coles B, Williams SM, Wilcock A, Johnson MJ. Association for Palliative Medicine for Great Britain and Ireland. Management of venous thromboembolism in patients with advanced cancer: a systematic review and meta-analysis. Lancet Oncol 2008; 9 (06) 577-584
• 59 Barginear MF, Gralla RJ, Bradley TP. et al. Investigating the benefit of adding a vena cava filter to anticoagulation with fondaparinux sodium in patients with cancer and venous thromboembolism in a prospective randomized clinical trial. Support Care Cancer 2012; 20 (11) 2865-2872